臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"su k y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 31-55 of 249 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-03-04T05:33:27Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-03-04T05:33:27Z	Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression	Chen Y.-J.; Roumeliotis T.I.; Chang Y.-H.; Chen C.-T.; Han C.-L.; Lin M.-H.; Chen H.-W.; Chang G.-C.; Chang Y.-L.; CHEN-TU WU; Lin M.-W.; Hsieh M.-S.; Wang Y.-T.; Chen Y.-R.; Jonassen I.; Ghavidel F.Z.; Lin Z.-S.; Lin K.-T.; Chen C.-W.; Sheu P.-Y.; Hung C.-T.; Huang K.-C.; Yang H.-C.; Lin P.-Y.; Yen T.-C.; Lin Y.-W.; Wang J.-H.; Raghav L.; Lin C.-Y.; Chen Y.-S.; Wu P.-S.; Lai C.-T.; Weng S.-H.; Su K.-Y.; Chang W.-H.; Tsai P.-Y.; Robles A.I.; Rodriguez H.; Hsiao Y.-J.; Chang W.-H.; Sung T.-Y.; Chen J.-S.; Yu S.-L.; Choudhary J.S.; Chen H.-Y.; Yang P.-C.; Chen Y.-J.
臺大學術典藏	2022-03-04T03:48:22Z	Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice	Hsu Y.-C.; Huang H.-P.; Yu I.-S.; Su K.-Y.; Lin S.-R.; WEI-CHOU LIN; Wu H.-L.; Shi G.-Y.; Tao M.-H.; Kao C.-H.; Wu Y.-M.; Martin P.E.; Lin S.-Y.; Yang P.-C.; Lin S.-W.
臺大學術典藏	2022-02-23T02:12:37Z	Decreased expressions of hepsin in human hepatocellular carcinomas	CHIEN-HUNG CHEN; Su K.-Y.; Tao M.-H.; Lin S.-W.; Su Y.-H.; Tsai Y.-C.; Cheng K.-C.; Jeng Y.-M.; Sheu J.-C.
臺大學術典藏	2022-02-22T05:34:31Z	Decreased expressions of hepsin in human hepatocellular carcinomas	CHIEN-HUNG CHEN; Su K.-Y.; Tao M.-H.; Lin S.-W.; Su Y.-H.; Tsai Y.-C.; Cheng K.-C.; Jeng Y.-M.; Sheu J.-C.
臺大學術典藏	2022-02-21T03:52:35Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; JIH-HSIANG LEE; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.
臺大學術典藏	2022-02-21T03:52:35Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏	2022-02-21T03:52:32Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-02-21T03:52:31Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-02-14T07:10:41Z	Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression	Chen Y.-J.; Roumeliotis T.I.; Chang Y.-H.; Chen C.-T.; Han C.-L.; Lin M.-H.; Chen H.-W.; Chang G.-C.; YIH-LEONG CHANG; Wu C.-T.; Lin M.-W.; Hsieh M.-S.; Wang Y.-T.; Chen Y.-R.; Jonassen I.; Ghavidel F.Z.; Lin Z.-S.; Lin K.-T.; Chen C.-W.; Sheu P.-Y.; Hung C.-T.; Huang K.-C.; Yang H.-C.; Lin P.-Y.; Yen T.-C.; Lin Y.-W.; Wang J.-H.; Raghav L.; Lin C.-Y.; Chen Y.-S.; Wu P.-S.; Lai C.-T.; Weng S.-H.; Su K.-Y.; Chang W.-H.; Tsai P.-Y.; Robles A.I.; Rodriguez H.; Hsiao Y.-J.; Chang W.-H.; Sung T.-Y.; Chen J.-S.; Yu S.-L.; Choudhary J.S.; Chen H.-Y.; Yang P.-C.; Chen Y.-J.
臺大學術典藏	2022-02-14T07:10:40Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2022-01-20T07:58:02Z	The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan	Lee C.-C.; Chang H.-H.; Lu M.-Y.; Yang Y.-L.; SHU-WEI CHOU; Lin D.-T.; Jou S.-T.; Yao M.; Li C.-C.; Yeh S.-P.; Chen M.-H.; Gau J.-P.; Li S.-S.; Wang P.-N.; Liu Y.-C.; Wang T.-F.; Tan T.-D.; Lee M.-Y.; Yu M.-S.; Wang C.-C.; Lin S.-C.; Chen Y.-C.; Su Y.-C.; Su K.-Y.; Lin K.-H.
臺大學術典藏	2021-11-03T05:24:54Z	Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan	Wu S.-G.; Liao W.-Y.; Su K.-Y.; Yu S.-L.; Huang Y.-L.; CHONG-JEN YU; Chih-Hsin Yang J.; Shih J.-Y.
臺大學術典藏	2021-11-03T02:33:02Z	Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan	Wu S.-G.; Liao W.-Y.; Su K.-Y.; Yu S.-L.; Huang Y.-L.; Yu C.-J.; Chih-Hsin Yang J.; JIN-YUAN SHIH
臺大學術典藏	2021-10-08T08:16:23Z	Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer	MONG-WEI LIN; Su K.-Y.; Su T.-J.; Chang C.-C.; Lin J.-W.; Lee Y.-H.; Yu S.-L.; Chen J.-S.; Hsieh M.-S.
臺大學術典藏	2021-10-08T08:16:16Z	Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression	Chen Y.-J.; Roumeliotis T.I.; Chang Y.-H.; Chen C.-T.; Han C.-L.; Lin M.-H.; Chen H.-W.; Chang G.-C.; Chang Y.-L.; Wu C.-T.; MONG-WEI LIN; Hsieh M.-S.; Wang Y.-T.; Chen Y.-R.; Jonassen I.; Ghavidel F.Z.; Lin Z.-S.; Lin K.-T.; Chen C.-W.; Sheu P.-Y.; Hung C.-T.; Huang K.-C.; Yang H.-C.; Lin P.-Y.; Yen T.-C.; Lin Y.-W.; Wang J.-H.; Raghav L.; Lin C.-Y.; Chen Y.-S.; Wu P.-S.; Lai C.-T.; Weng S.-H.; Su K.-Y.; Chang W.-H.; Tsai P.-Y.; Robles A.I.; Rodriguez H.; Hsiao Y.-J.; Chang W.-H.; Sung T.-Y.; Chen J.-S.; Yu S.-L.; Choudhary J.S.; Chen H.-Y.; Yang P.-C.; Chen Y.-J.
臺大學術典藏	2021-09-17T05:41:27Z	Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis	Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; KAI-LUN YU; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C.
臺大學術典藏	2021-08-31T03:33:45Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	SHU-YUNG LIN; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏	2021-08-23T03:20:34Z	Impact of EGFR mutation detection methods on the efficacy of erlotinib in patients with advanced EGFR-wild type lung adenocarcinoma	Tseng J.-S.; Wang C.-L.; Huang M.-S.; CHUNG-YU CHEN; Chang C.-Y.; Yang T.-Y.; Tsai C.-R.; Chen K.-C.; Hsu K.-H.; Tsai M.-H.; Yu S.-L.; Su K.-Y.; Wu C.-W.; Yang C.-T.; Chen Y.-M.; Chang G.-C.
臺大學術典藏	2021-08-20T08:00:40Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Lin S.-Y.; Yang C.-Y.; BIN-CHI LIAO; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏	2021-08-20T08:00:39Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; BIN-CHI LIAO; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2021-08-20T08:00:38Z	Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; BIN-CHI LIAO; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏	2021-07-13T06:04:33Z	Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study	Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; LEE JIH-HSIANG; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.
臺大學術典藏	2021-07-13T06:04:33Z	Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan	Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; LEE JIH-HSIANG; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏	2021-07-13T06:04:30Z	Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors	Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; LEE JIH-HSIANG; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.

Showing items 31-55 of 249 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2817371
	???header.visitor??? : 27741508 ???header.onlineuser??? : 326 ???header.sponsordeclaration???